NHS Innovation Accelerator
Amir Hashmi is an accomplished leader with extensive experience in technology services and healthcare innovation. Currently serving as CEO of zsah since February 2002, Amir oversees specialized technology services, including consulting and managed services in Cloud/Infra, Devops, NetOps, and Data. In addition, Amir chairs the Data Trust Committee at University College London Hospitals NHS Foundation Trust, facilitating patient data access for research purposes. As a mentor at the NHS Innovation Accelerator, Amir provides guidance to develop health and social care innovations. Amir is also the founder of Shooting Brake, a unique auction platform utilizing advanced machine learning technology. Previous roles include board member at CoolHarbour and technical advisory positions at Deutsche Bank and BP. Amir holds an Executive MBA from Smartly Institute and a Bachelor's degree in Multimedia Computing and Software Engineering from the University of Westminster.
This person is not in the org chart
This person is not in any teams
NHS Innovation Accelerator
1 followers
The NHS Innovation Accelerator (NIA) is an NHS England Initiative delivered in partnership with the country’s 15 Health Innovation Networks (HINs) and the Accelerated Access Collaborative. Hosted by UCLPartners, it supports delivery of the Five Year Forward View by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing real time practical insights on spread to inform national strategy. Fellows supported by the NIA all share a set of values and passion for scaling evidence-based innovation to benefit a wider population, with a commitment to share their learnings. Some impressive results have been achieved by Fellows since the NIA launched in July 2015: 2,980 additional NHS sites now using NIA innovations; £203 million in external funds secured; 193 awards won; 1,145 jobs created; and 57 innovations selling internationally. In addition, impact data is already available at adopter sites and this demonstrates earlier intervention, reductions in complications and emergency admissions, alongside cost savings.